Evofem Biosciences Issues Mid-Year 2020 Letter to Stockholders
- Wednesday, July 1, 2020, 7:11
- PR Newswire
- Add a comment
SAN DIEGO, July 1, 2020 /PRNewswire/ — Evofem Biosciences, Inc. (NASDAQ: EVFM), a commercial-stage biopharmaceutical company, today announced that it has issued a letter to its stockholders providing an update on recent events and outlook for the remainder of 2020 and early 2021. The…
About the Author
admin has written 20655 stories on this site.